Skip to main content

Table 1 Height and BA-CA for Groups A to D

From: Growth characteristics of children with 21-hydroxylase deficiency and the value of steroid hormones in height assessment

 

Group A

Group B

Group C

Group D

 

HSDS-THSDS

HSDS-THSDS

HBASDS-THSDS

BA-CA

HSDS-THSDS

HBASDS-THSDS

BA-CA

FHSDS-THSDS

SW-male

1.00

(− 0.79 to 3.22)

(n = 8)

− 0.24

(− 1.83 to 2.56)

(n = 28)

− 0.81

(− 3.85 to 2.72)

(n = 28)

0.03

(− 2.33 to 3.40)

(n = 28)

0.74

(− 1.80 to 2.72)

(n = 8)

− 2.21

(− 4.17 to − 0.86)

(n = 8)*

2.77

(1.18 to 6.19)

(n = 8)*

− 4.84

(n = 1)

SW-female

0.59

(− 0.51 to 1.37)

(n = 4)

0.05

(− 1.96 to 2.92)

(n = 15)

− 0.69

(− 3.31 to 2.00)

(n = 15)

0.28

(− 0.94 to 1.66)

(n = 15)

0.91

(− 0.56 to 2.41)

(n = 5)

− 0.91

(− 2.66 to 0.31)

(n = 5)

2.66

(2.19 to 3.44)

(n = 5)*

− 2.01

(− 2.69 to − 0.48)

(n = 3)

SV-male

− 0.28

(n = 1)

1.77

(0.66 to 4.23)

(n = 3)

− 0.77

(− 2.63 to 2.66)

(n = 3)

3.56

(− 1.14 to 4.87)

(n = 3)

1.71

(0.92 to 5.16)

(n = 5)

− 0.78

(− 2.92 to 1.06)

(n = 5)

3.51

(1.93 to 6.44)

(n = 5)

− 2.82

(− 4.03 to − 1.61)

(n = 2)

SV-female

− 0.50

(− 0.60 to − 0.40)

(n = 2)

− 1.40

(− 1.50 to − 1.30)

(n = 2)

0.87

(0.84 to 0.89)

(n = 2)

0.45

(− 0.60 to 2.53)

(n = 5)

− 0.94

(− 2.17 to − 0.05)

(n = 5)

2.30

(0.19 to 4.23)

(n = 5)

− 0.79

(− 2.43 to 0.80)

(n = 9)

NC-male

0.5

(n = 1)

− 2.40

(n = 1)

3.35

(n = 1)

2.37

(0.27 to 4.11)

(n = 5)

− 1.43

(− 2.83 to 0.31)

(n = 5)

4.17

(1.67 to 5.79)

(n = 5)

–-

NC-female

1.58

(1.49 to 1.66)

(n = 2)

0.13

(− 0.61 to 0.86)

(n = 2)

1.46

(0.83 to 2.09)

(n = 2)

− 0.40

(− 0.70 to 1.39)

(n = 4)

Overall

0.69

(− 0.26,1.43)

(n = 13)

− 0.19

(− 1.20,0.78)

(n = 49)

− 0.82

(− 1.70,0.29)

(n = 49)

0.28

(− 0.32,1.00)

(n = 49)

1.43

(0.34,2.38)

(n = 30)*

− 1.21

(− 2.29,− 0.46)

(n = 30)

2.66

(1.89,4.19)

(n = 30)*

− 0.79

(− 2.01,− 0.37)

(n = 19)

  1. *P < 0.05 for the SW-male, SW-female and overall in Group C compared with Group B